Maynard Um
-
-
-
-
-
-
-
William Blair stays Outperform on Viking Therapeutic (VKTX) amid 'torrid pace' in advancing VK2735
-
-
-
-
-
-
-
Viking Therapeutics (VKTX) Misses Q4 EPS by 48c
-
-
-
-
-
-
-
Canaccord Genuity Starts Viking Therapeutic (VKTX) at Buy
-
-
-
-
-
-
-
Viking Therapeutics (VKTX) call put ratio 7.8 calls to 1 put with a focus on January 45 calls
-
-
-
-
-
-
-
Viking Therapeutics (VKTX) call put ratio 2.8 calls to 1 put with a focus on August 22 weekly calls
-
-
-
-
-
-
-
William Blair on Viking Therapeutic (VKTX) Sell-Off: 'extreme and unwarranted'
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)
-
404,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

